Pfannenberg Highlights Compact Packaged Chillers for Efficient and Reliable Cooling

CCE Chillers offer simple installation, low maintenance, and high corrosion-resistance for the medical industry

Pfannenberg, Inc., a leading global manufacturer of thermal management and signaling technologies, highlights its line of high-efficiency Compact Packaged (CCE) Chillers for a range of commercial and industrial applications, including the medical industry. These compact chillers are an ideal centralized and cost-effective solution for use in centrifuge cooling applications in blood and fluid testing labs where precise temperature control and reliability are critical.

Pfannenberg’s CCE compact packaged chillers provide years of trouble-free operation. Combining durable, highly reliable components with a compact and lightweight design, these chillers offer easy transportation and consistent reliability. Their heavy-duty construction and highly serviceable design also mean reduced maintenance costs and long service life. Each chiller model comes with comprehensive equipment for easy installation and reliable operation, complete with a Hydraulic Bypass for increased protection against system failure.

Increasing productivity and product quality doesn’t need to come at a cost to a business’s bottom line. Utilizing Pfannenberg’s compact chillers maximizes business efficiency while reducing energy and maintenance costs. These compact chillers feature Pfannenberg’s Liquid Solutions technology with optimum corrosion resistance when used with Pfannenberg’s premix Ethylene and Propylene Glycol coolant. The chiller’s non-ferrous tank design greatly minimizes corrosion potential, additionally extending chiller life.

Pfannenberg’s compact chillers include the CCE 6301, 6401, and 6601. These models feature 2.4 kW to 6.5 kW capacity. Each CCE chiller offers standard-size features in a compact model. Plus, a single-phase power requirement makes installation a breeze in both commercial and industrial settings.<

Pfannenberg offers customers unparalleled experience and high-quality components providing a high mean time between failures, and high reliability because of it. Plus, all Pfannenberg chillers consistently achieve top grades in energy consumption and efficiency. Centralized cooling can be achieved with a single chiller or chillers can be decentralized, with a chiller for each application. Pfannenberg’s systems are customizable depending on application needs.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”